Liquent Announces New Solution Strategies Following Merger with Datafarm

HORSHAM, Pa., Sept. 8 /PRNewswire/ -- Liquent Inc., the global leader in regulatory information management solutions and services, revealed today its new solution branding positioning. The announcement comes approximately three months following the merger of the Liquent and Datafarm organizations announced June 1, 2010.

"The combined strengths of Liquent and Datafarm offers the new Liquent greater opportunities to serve our clients and the Life Sciences market place," said Rick Riegel, CEO of Liquent. "We are excited to provide the industry with an informative first look at our strategic direction and share a number of exciting new products that represent a new chapter in Liquent's long history of innovation.  Our new solutions were developed to support the market demands of Tier1, Tier2 and Tier3 Life Sciences organizations."

"Liquent hosted a series of web conferences with its client community in August and the feedback has been wholly positive," adds Jim Nichols, Liquent's Vice President, Strategy. "In times of exciting change like this merger, we are adamant about clearly articulating our plans to our clients and the market."

In the web conferences, Liquent unveiled its new combined solution portfolio and its branding. Liquent InSight® will be repositioned with three core focus areas: Liquent InSight for Registrations, Liquent InSight for Submissions and Liquent InSight for Viewing. These software solutions are already widely used in the industry and the new positioning will better enable Liquent's clients to adopt the technology into their organizations. Liquent's regulatory operations outsourcing offerings will be rebranded as Liquent Direct® and also offer three core focus areas: regulatory affairs, regulatory operations and medical writing.

Liquent's latest products and services will be showcased at its upcoming European conference, Liquent Horizons, scheduled to be held in Paris, France on September 13-15, 2010. In addition to its product test lab, the conference will also offer presentations provided by industry experts and is expected to have its highest attendance levels ever in its history.

For more information, visit www.liquent.com.

ABOUT LIQUENT

Liquent regulatory solutions provide software and related regulatory and clinical services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.

Liquent is owned by Marlin Equity Partners.

About Marlin Equity Partners

Marlin Equity Partners is a Los Angeles, California-based private investment firm with over $1 billion of capital under management.  The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries that are in the process of undergoing varying degrees of operational, financial or market-driven change where its capital base, industry relationships and extensive network of operational resources significantly strengthens a company's outlook and enhances value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 35 acquisitions. For more information, please visit www.marlinequity.com.

CONTACT:  Jim Nichols, Vice President, Strategy, +1-215-328-4320

SOURCE Liquent Inc.